Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Harrison Gunn

ID: 1b83cf65-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Revises Draft Guidance on Substantial Evidence of Effectiveness to Clarify Confirmatory Evidence Requirements for a Single Clinical Investigation

Big Molecule Watch · August 14, 2026

FDA Expands Indication for Vertex’s CASGEVY to Children Aged Two Years and Older

Big Molecule Watch · July 8, 2026

Samsung Bioepis Launches OPUVIZ in Europe

Big Molecule Watch · June 2, 2026

Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion

Big Molecule Watch · May 4, 2026

Formycon and Regeneron Settle European Aflibercept Biosimilar Litigation

Big Molecule Watch · March 30, 2026

Previous

12...7

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog